The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 5 , Pages 1190-1194 , May 2009

Stability of an autologous platelet clot in the pericardial sac: An experimental and clinical study

  • Leonard M. Rademakers, MD

      Affiliations

    • Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiothoracic Surgery, Maastricht University Medical Center, Maastricht, The Netherlands
    • Corresponding Author InformationAddress for reprints: Leonard M. Rademakers, MD, Maastricht University Medical Center, Department of Cardiothoracic Surgery, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
    • ,
  • Paul F. Gründeman, MD, PhD

      Affiliations

    • Laboratory of Experimental Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Robert W. Bolderman, MD

      Affiliations

    • Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiothoracic Surgery, Maastricht University Medical Center, Maastricht, The Netherlands
    • ,
  • Frederik H. van der Veen, PhD

      Affiliations

    • Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiothoracic Surgery, Maastricht University Medical Center, Maastricht, The Netherlands
    • ,
  • Jos G. Maessen, MD, PhD

      Affiliations

    • Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiothoracic Surgery, Maastricht University Medical Center, Maastricht, The Netherlands

Received 18 July 2008 ,Revised 15 September 2008 ,Accepted 9 October 2008.

References 

  1. Spodick DH. Physiology of the normal pericardium: functions of the pericardium. In:  Spodick DH editors. The pericardium: A comprehensive textbook. New York: Marcel Dekker; 1997;p. 15–26
  2. Laham RJ, Hung D, Simons M. Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery. Clin Cardiol. 1999;22(1 Suppl. 1):I6–I9
  3. Laham RJ, Rezaee M, Post M, Xu X, Sellke FW. Intrapericardial administration of basic fibroblast growth factor: myocardial and tissue distribution and comparison with intracoronary and intravenous administration. Catheter Cardiovasc Interv. 2003;58:375–381
  4. Stoll HP, Carlson K, Keefer LK, Hrabie JA, March KL. Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries: direct comparison with endoluminal delivery. Clin Cardiol. 1999;22(1 Suppl. 1):I10–I16
  5. Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16:1043–1054
  6. Currie LJ, Sharpe JR, Martin R. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. Plast Reconstr Surg. 2001;108:1713–1726
  7. Tabata S, Eckert HG, Kellner HM, Hayashi S, Fujimoto K. Pharmacokinetic study of a fibrin adhesive agent, Beriplast in rats. Oyo Yakuri-Pharmacometrics. 1986;31:1123–1127
  8. Yazawa M, Ogata H, Nakajima T, Mori T, Watanabe N, Handa M. Basic studies on the clinical applications of platelet-rich plasma. Cell Transplant. 2003;12:509–518
  9. Mogan C, Larson DF. Rationale of platelet gel to augment adaptive remodeling of the injured heart. J Extra Corpor Technol. 2004;36:191–196
  10. Christensen K, Vang S, Brady C, Isler J, Allen K, Anderson J, et al. Autologous platelet gel: an in vitro analysis of platelet-rich plasma using multiple cycles. J Extra Corpor Technol. 2006;38:249–253
  11. Everts PA, Knape JT, Weibrich G, Schonberger JP, Hoffmann J, Overdevest EP, et al. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol. 2006;38:174–187
  12. Lundquist R, Dziegiel MH, Agren MS. Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin. Wound Repair Regen. 2008;16:356–363
  13. Niewiarowski S, Stewart GJ, Nath N, Sha AT, Lieberman GE. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction. Am J Physiol. 1975;229:737–745
  14. Hantgan RR, Taylor RG, Lewis JC. Platelets interact with fibrin only after activation. Blood. 1985;65:1299–1311
  15. Mazzucco L, Balbo V, Cattana E, Borzini P. Platelet-rich plasma and platelet gel preparation using Plateltex(R). Vox Sang. 2008;94:202–208
  16. Buchta C, Hedrich HC, Macher M, Hocker P, Redl H. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel. Biomaterials. 2005;26:6233–6241
  17. Porter JM, Ball AP, Silver D. Mesothelial fibrinolysis. J Thorac Cardiovasc Surg. 1971;62:725–730
  18. Porter JM, Ball AP, Silver D. The mechanism of blood clot resorption from mesothelial spaces. Surg Forum. 1971;22:83–84
  19. Lardinois D, Jung FJ, Opitz I, Rentsch K, Latkoczy C, Vuong V, et al. Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma. J Thorac Cardiovasc Surg. 2006;131:697–703
  20. Ishii I, Mizuta H, Sei A, Hirose J, Kudo S, Hiraki Y. Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br. 2007;89:693–700
  21. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004;10:403–409
  22. Everts PA, Overdevest EP, Jakimowicz JJ, Oosterbos CJ, Schonberger JP, Knape JT, et al. The use of autologous platelet-leukocyte gels to enhance the healing process in surgery, a review. Surg Endosc. 2007;21:2063–2068
  23. Driver VR, Hanft J, Fylling CP, Beriou JM. Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52:68–74
  24. Nair LS, Laurencin CT. Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv Biochem Eng Biotechnol. 2006;102:47–90
  25. Hou Q, Chau DY, Pratoomsoot C, Tighe PJ, Dua HS, Shakesheff KM, et al. In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. J Pharm Sci. 2008;97:3972–3980

PII: S0022-5223(08)01692-9

doi: 10.1016/j.jtcvs.2008.10.012

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 5 , Pages 1190-1194 , May 2009

Article Tools

* Image Usage & Resolution